SOURCE: InteGreat

August 03, 2006 08:00 ET

InteGreat Teams With IntelliDose to Offer Medical Oncology EHR Capabilities for Multi-Specialty Group Practices

Great Falls, Mont., Clinic First to Embed Oncology Software in IC-Chart

SCOTTSDALE, AZ -- (MARKET WIRE) -- August 3, 2006 -- InteGreat, a leading provider of electronic health record (EHR) systems for physician group practices, today announced its exclusive partnership with IntelliDose®, an oncology clinical information software solution designed by oncologists to optimize safe and effective healthcare for cancer patients. By embedding IntelliDose software into InteGreat's IC-Chart EHR solution, physicians in a multi-specialty group practice that includes oncology can house patient information in a single database.

IntelliDose automates the cancer care process to achieve the highest levels of patient safety and practice efficiency. The software calculates chemotherapy dosages, safeguards against potential overdoses and alerts physicians throughout the practice to potential contraindications. IntelliDose also prints out doctors' orders, thereby eliminating handwritten errors, and patient education information sheets listing potential side effects.

"By embedding the leading clinical oncology software into our product, we'll gain a tremendous advantage in attracting large multi-specialty group practices with an oncology arm," says InteGreat's President David Koeller.

"The partnership is a win-win situation for both companies. IntelliDose can benefit from InteGreat's existing client base of multi-specialty practices, while InteGreat will reap the benefits of providing the No. 1 clinical oncology product on the market," says Fran Massimiano, vice president of sales for IntrinsiQ Research, Inc., manufacturer of IntelliDose.

Great Falls Clinic in Great Falls, Mont., currently is integrating IntelliDose, which provides a seamless interface with its existing InteGreat's EHR, and is scheduled to go live at the end of August. "We immediately recognized the inherent value of accessing oncology patient records across multiple medical disciplines," says Mary Frances Frieling, BSN, the clinic's director of informatics. "By accessing one chart that contains a cancer patient's complete medical history, including lab results, chemotherapy, radiation treatments and prescriptions, our clinic physicians can ensure greater patient safety and care and reduce risk of errors."

About IntelliDose

IntelliDose® is produced by IntrinsiQ Research, Inc., the market leader in information management for the cancer care market. IntrinsiQ is a fast-growing, privately held company located in Waltham, Mass. The company is focused entirely on the cancer care market, the second largest market in healthcare. IntrinsiQ has established unique, innovative technology platforms that are significantly impacting many aspects of the continuum of care in cancer. The company's proprietary IntelliDose technology is the leading software product for automating the chemotherapy dose calculation process. IntelliDose is used in a rapidly growing list of over 100 oncology practices, including some of the most prestigious cancer centers in the United States. For more information, visit www.intellidose.com.

About InteGreat

Scottsdale, Ariz.-based InteGreat is the leading provider of electronic medical record software that enables physician group practices to enhance patient care while increasing productivity, eliminating paperwork and gaining a rapid return-on-investment. InteGreat's user-friendly, web-based modular products provide management of clinical data, including transcription records, lab results and radiology reports, and the products capture critical patient health summary data and medications. For more information, call 800.676.1360 or visit www.igreat.com.

Contact Information